pharma · Eczema · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency
Hong Kong Baptist
Hong Kong Baptist University
Hong Kong Baptist is a pharma organization headquartered in CN. Primary therapeutic focus areas include Eczema, GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency, Infantile Colic, Feeding and Eating Disorders of C
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 18
- Drugs
- 14
- Patents
- 0
glargine + exenatide
Approved · small molecule · Type 2 Diabetes Mellitus
glargine + exenatide for Type 2 Diabetes Mellitus is a Approved program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).
Internal code ESR-14-10352
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Hong Kong Baptist University
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Type 2 Diabetes Mellitus
- Status
- completed
- Trials
- 1